MediPal (OTCMKTS: MAHLY) represents the American depositary receipts of Medipal Holdings Corporation, a Tokyo‐based integrated healthcare distributor. The company specializes in the procurement, warehousing and delivery of prescription pharmaceuticals, over-the-counter medicines, medical devices and nutritional supplements. Through its extensive logistics network, MediPal services a wide range of clients including retail pharmacies, drugstores, hospitals and clinics across Japan.
In addition to its core distribution activities, MediPal offers ancillary services such as in-store pharmacy management support, inventory control systems and consulting for healthcare retailers. The company’s Retail & Consumer Business segment provides consumer health products and lifestyle goods under private-label and third-party brands. MediPal’s Hospital Business unit supplies medical equipment, surgical disposables and diagnostics to healthcare institutions, while its Pharma Solutions branch manages contract logistics and regulatory compliance services for pharmaceutical manufacturers.
Beyond its domestic operations, MediPal has established a presence in key Asian markets through subsidiaries and joint ventures, facilitating cross-border procurement and distribution partnerships. Headquartered in Tokyo, the company is governed by a board of directors with deep expertise in pharmaceuticals, logistics and healthcare services. Its ADRs trade on the OTC Markets under the symbol MAHLY, providing international investors access to one of Japan’s leading healthcare distribution platforms.
AI Generated. May Contain Errors.
